# EC_number_0111: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/EC_number_0111.txt)

**Task:** `EC_number`  
**Author key, unchanged:** **B** — 2.7.11.1

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MELVLCFVIITISGVIRESSALLLRSPTSNDVFGELVASAERAQPLATRLTKRISRLNFNDREDDFWEDHGDASWNNSYTLVNGRTTLGSENRRRPASHSLIERPYYRDGRLSPVLGVQERRGRSVHSYHEEPVSFFDQRAFDEYTFRRRSQLHRQRARAGLRSRIKQNVRRLWTSARGAVRGWGRRVRRKIGDLFVGHLMPQLRRLRFWDQGLPPVVPPLIGNEPGQASVALVAERMEARLREKTLTEKNPTEAQQAVGTYLINSAENTWFISIPGGRYILLKKRGFLGGGGFGLVYHVEHPTTGQPFALKIFVQRVMNNEVGDKISDLIEDEFGVMKYFPPEWTPARMYSELRFMVPLLKLRVLGKPEFQDARNHLRIFSVCALFPKAQGDLEEAAALLADMDRTNAYNMRMSSTIQMVKLLARFHAFGLVHGDVKLQNFLVDKSGLLLLSDFTQILRTNERRYPPVVTVLYMSPEIATCLITRLRNAIPYTAEIDSWMLGISLYRLWCGDFPFGITLDATALQVAGIVIRSSASSLDFASCHDIPEQFREMIVGFLRKTPGVRLSPQQALEQFSLLNWKGPSPASDTASESEPVSTEEAALLQKE

[Multiple Choices]
A. 2.7.11.24
B. 2.7.11.1
C. 3.2.1.55
D. 1.14.13.238
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Commission (EC) Number Prediction, which is to predict the complete 4-digit Enzyme Commission (EC) number for a given protein. The EC number is a numerical classification that categorizes enzymes based on the chemical reactions they catalyze. You should select the most accurate EC number from the provided options based on the protein's sequence.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for Toxoplasma gondii ROP17. That entry assigns EC 2.7.11.1 and records a protein-phosphorylation reaction with experimental evidence attribution (ECO:0000269). The cited primary study is identified in the annotation, though it was not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is consistent with a protein kinase, but that general inference does not distinguish EC 2.7.11.1 from the other kinase option, 2.7.11.24; the non-kinase options are less consistent with the sequence.


**Missing item-specific fact**

> The specific functional identification of this sequence as T. gondii ROP17 and its annotated catalytic activity are not supplied in the question.


**Reason**

> Choosing between the two kinase EC numbers requires protein-specific functional or homology information beyond the general kinase features inferable from the sequence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched-record annotation supports B. The sequence alone may not distinguish the kinase subclasses, but the reviewer evidence does not support another listed EC as an alternative for this protein.


### Important caveats

- The UniProt record and its evidence attribution support the key, but the cited primary paper was not independently assessed.
- The reviewer-only accession and annotations were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a protein kinase, but that general inference does not distinguish EC 2.7.11.1 from the other kinase option, 2.7.11.24; the non-kinase options are less consistent with the sequence.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific functional identification of this sequence as T. gondii ROP17 and its annotated catalytic activity are not supplied in the question.",
    "reason": "Choosing between the two kinase EC numbers requires protein-specific functional or homology information beyond the general kinase features inferable from the sequence."
  },
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H1",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for Toxoplasma gondii ROP17. That entry assigns EC 2.7.11.1 and records a protein-phosphorylation reaction with experimental evidence attribution (ECO:0000269). The cited primary study is identified in the annotation, though it was not independently reviewed here."
  },
  "important_caveats": [
    "The UniProt record and its evidence attribution support the key, but the cited primary paper was not independently assessed.",
    "The reviewer-only accession and annotations were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-record annotation supports B. The sequence alone may not distinguish the kinase subclasses, but the reviewer evidence does not support another listed EC as an alternative for this protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for Toxoplasma gondii ROP17. That entry assigns EC 2.7.11.1 and records a protein-phosphorylation reaction with experimental evidence attribution (ECO:0000269). The cited primary study is identified in the annotation, though it was not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "H1", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is consistent with a protein kinase, but that general inference does not distinguish EC 2.7.11.1 from the other kinase option, 2.7.11.24; the non-kinase options are less consistent with the sequence.",
    "missing_item_specific_fact": "The specific functional identification of this sequence as T. gondii ROP17 and its annotated catalytic activity are not supplied in the question.",
    "reason": "Choosing between the two kinase EC numbers requires protein-specific functional or homology information beyond the general kinase features inferable from the sequence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-record annotation supports B. The sequence alone may not distinguish the kinase subclasses, but the reviewer evidence does not support another listed EC as an alternative for this protein."
  },
  "important_caveats": [
    "The UniProt record and its evidence attribution support the key, but the cited primary paper was not independently assessed.",
    "The reviewer-only accession and annotations were not provided to the evaluated model."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q2PAY3 (ROP17_TOXGO) assigns EC 2.7.11.1 (Serine/threonine-protein kinase) with evidence code ECO:0000269 (inferred from direct assay) from PubMed 24832449 (Etheridge et al. 2014, Cell Host Microbe). Catalytic activity reactions for both Ser and Thr phosphorylation with ATP are annotated. The sequence (608 AA) matches the benchmark input exactly. This is experimental evidence, not merely computational inference.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H2](#evidence-h2), [H5](#evidence-h5), [H6](#evidence-h6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> In principle, a model could attempt to identify kinase-like features (glycine-rich loop, catalytic domain architecture) to eliminate C (glycosidase) and D (monooxygenase), and note the absence of MEKK4-specific domains (SH3, CRD) to argue against A (2.7.11.24). However, ROP17 is a pseudokinase with highly divergent catalytic residues: the canonical VAIK lysine is absent, HRD→HGD, and DFG→DFP substitutions are present. This makes reliable kinase-motif recognition from sequence alone unreliable.


**Missing item-specific fact**

> The specific experimental demonstration (Etheridge et al. 2014) that ROP17 phosphorylates IRG proteins (Irga6, Irgb6) and the resulting EC 2.7.11.1 assignment. Without knowing this is ROP17 and its characterized substrates, the distinction between 2.7.11.1 (general Ser/Thr kinase) and 2.7.11.24 (MEKK4/MAP3K4) cannot be resolved from sequence alone, especially given the pseudokinase divergence.


**Reason**

> While options C and D (glycosidase, monooxygenase) could potentially be eliminated by recognizing any kinase-like fold, the critical A-vs-B distinction (general Ser/Thr kinase vs. MEKK4) requires knowledge that ROP17 is not a MAP-kinase-pathway component and its specific experimental characterization. The pseudokinase nature of ROP17 means canonical kinase motifs are absent or highly modified, undermining sequence-based reasoning for even the broad kinase classification.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Both A (2.7.11.24, MEKK4) and B (2.7.11.1, general Ser/Thr kinase) are Ser/Thr protein kinases. Without clear MEKK4-specific domain architecture visible in the sequence (the protein lacks SH3 and CRD domains typical of MEKK4), and given the pseudokinase divergence, a model could reasonably hesitate between these two kinase EC numbers. The distinction ultimately rests on substrate specificity knowledge not derivable from the sequence.


### Important caveats

- ROP17 is classified as a pseudokinase with non-canonical catalytic residues (HGD instead of HRD, DFP instead of DFG), making standard kinase-motif detection unreliable.
- The EC 2.7.11.1 assignment is based on experimental kinase assay data (ECO:0000269), not sequence homology or computational prediction.
- The sequence is 608 AA and includes an N-terminal signal peptide and rhoptry-targeting region, with the kinase-like domain in the C-terminal portion.
- EC 2.7.11.1 is the 'default' Ser/Thr kinase EC number used when no more specific subclassification applies; this is a database classification convention rather than a mechanistically distinct reaction.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "In principle, a model could attempt to identify kinase-like features (glycine-rich loop, catalytic domain architecture) to eliminate C (glycosidase) and D (monooxygenase), and note the absence of MEKK4-specific domains (SH3, CRD) to argue against A (2.7.11.24). However, ROP17 is a pseudokinase with highly divergent catalytic residues: the canonical VAIK lysine is absent, HRD→HGD, and DFG→DFP substitutions are present. This makes reliable kinase-motif recognition from sequence alone unreliable.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific experimental demonstration (Etheridge et al. 2014) that ROP17 phosphorylates IRG proteins (Irga6, Irgb6) and the resulting EC 2.7.11.1 assignment. Without knowing this is ROP17 and its characterized substrates, the distinction between 2.7.11.1 (general Ser/Thr kinase) and 2.7.11.24 (MEKK4/MAP3K4) cannot be resolved from sequence alone, especially given the pseudokinase divergence.",
    "reason": "While options C and D (glycosidase, monooxygenase) could potentially be eliminated by recognizing any kinase-like fold, the critical A-vs-B distinction (general Ser/Thr kinase vs. MEKK4) requires knowledge that ROP17 is not a MAP-kinase-pathway component and its specific experimental characterization. The pseudokinase nature of ROP17 means canonical kinase motifs are absent or highly modified, undermining sequence-based reasoning for even the broad kinase classification."
  },
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "C7",
      "H2",
      "H5",
      "H6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q2PAY3 (ROP17_TOXGO) assigns EC 2.7.11.1 (Serine/threonine-protein kinase) with evidence code ECO:0000269 (inferred from direct assay) from PubMed 24832449 (Etheridge et al. 2014, Cell Host Microbe). Catalytic activity reactions for both Ser and Thr phosphorylation with ATP are annotated. The sequence (608 AA) matches the benchmark input exactly. This is experimental evidence, not merely computational inference."
  },
  "important_caveats": [
    "ROP17 is classified as a pseudokinase with non-canonical catalytic residues (HGD instead of HRD, DFP instead of DFG), making standard kinase-motif detection unreliable.",
    "The EC 2.7.11.1 assignment is based on experimental kinase assay data (ECO:0000269), not sequence homology or computational prediction.",
    "The sequence is 608 AA and includes an N-terminal signal peptide and rhoptry-targeting region, with the kinase-like domain in the C-terminal portion.",
    "EC 2.7.11.1 is the 'default' Ser/Thr kinase EC number used when no more specific subclassification applies; this is a database classification convention rather than a mechanistically distinct reaction."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Both A (2.7.11.24, MEKK4) and B (2.7.11.1, general Ser/Thr kinase) are Ser/Thr protein kinases. Without clear MEKK4-specific domain architecture visible in the sequence (the protein lacks SH3 and CRD domains typical of MEKK4), and given the pseudokinase divergence, a model could reasonably hesitate between these two kinase EC numbers. The distinction ultimately rests on substrate specificity knowledge not derivable from the sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q2PAY3 (ROP17_TOXGO) assigns EC 2.7.11.1 (Serine/threonine-protein kinase) with evidence code ECO:0000269 (inferred from direct assay) from PubMed 24832449 (Etheridge et al. 2014, Cell Host Microbe). Catalytic activity reactions for both Ser and Thr phosphorylation with ATP are annotated. The sequence (608 AA) matches the benchmark input exactly. This is experimental evidence, not merely computational inference.",
    "evidence_ids": ["C4", "C5", "C6", "C7", "H2", "H5", "H6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "In principle, a model could attempt to identify kinase-like features (glycine-rich loop, catalytic domain architecture) to eliminate C (glycosidase) and D (monooxygenase), and note the absence of MEKK4-specific domains (SH3, CRD) to argue against A (2.7.11.24). However, ROP17 is a pseudokinase with highly divergent catalytic residues: the canonical VAIK lysine is absent, HRD→HGD, and DFG→DFP substitutions are present. This makes reliable kinase-motif recognition from sequence alone unreliable.",
    "missing_item_specific_fact": "The specific experimental demonstration (Etheridge et al. 2014) that ROP17 phosphorylates IRG proteins (Irga6, Irgb6) and the resulting EC 2.7.11.1 assignment. Without knowing this is ROP17 and its characterized substrates, the distinction between 2.7.11.1 (general Ser/Thr kinase) and 2.7.11.24 (MEKK4/MAP3K4) cannot be resolved from sequence alone, especially given the pseudokinase divergence.",
    "reason": "While options C and D (glycosidase, monooxygenase) could potentially be eliminated by recognizing any kinase-like fold, the critical A-vs-B distinction (general Ser/Thr kinase vs. MEKK4) requires knowledge that ROP17 is not a MAP-kinase-pathway component and its specific experimental characterization. The pseudokinase nature of ROP17 means canonical kinase motifs are absent or highly modified, undermining sequence-based reasoning for even the broad kinase classification."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Both A (2.7.11.24, MEKK4) and B (2.7.11.1, general Ser/Thr kinase) are Ser/Thr protein kinases. Without clear MEKK4-specific domain architecture visible in the sequence (the protein lacks SH3 and CRD domains typical of MEKK4), and given the pseudokinase divergence, a model could reasonably hesitate between these two kinase EC numbers. The distinction ultimately rests on substrate specificity knowledge not derivable from the sequence."
  },
  "important_caveats": [
    "ROP17 is classified as a pseudokinase with non-canonical catalytic residues (HGD instead of HRD, DFP instead of DFG), making standard kinase-motif detection unreliable.",
    "The EC 2.7.11.1 assignment is based on experimental kinase assay data (ECO:0000269), not sequence homology or computational prediction.",
    "The sequence is 608 AA and includes an N-terminal signal peptide and rhoptry-targeting region, with the kinase-like domain in the C-terminal portion.",
    "EC 2.7.11.1 is the 'default' Ser/Thr kinase EC number used when no more specific subclassification applies; this is a database classification convention rather than a mechanistically distinct reaction."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact supplied sequence matches the UniProt entry, which assigns EC 2.7.11.1 and records serine- and threonine-phosphorylation reactions. The threonyl reaction carries experimental evidence (ECO:0000269); the underlying paper was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence has a eukaryotic protein-kinase-like catalytic domain, including a glycine-rich region and kinase catalytic motifs, so a protein kinase EC is a much better fit than the glycosidase or monooxygenase choices. Its signal-peptide-like N-terminus and long extension before the kinase domain are more consistent with a specialized secretory kinase than a conventional MAP kinase; the sequence also lacks the characteristic MAPK activation-loop TXY motif. These transferable features favor the broad serine/threonine-protein kinase class, B, over the MAPK-specific alternative A.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Family-level sequence and architecture features credibly distinguish the offered serine/threonine kinase option from the alternatives. They do not independently establish the exact physiological substrates or experimental activity, but that finer proof is not needed to make a meaningful choice among these options.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The kinase-like sequence supports a protein kinase classification, while the alternatives describe a more specific MAPK class or unrelated enzyme activities; no second option is comparably defensible from the supplied sequence.


### Important caveats

- The family-level inference supports the choice probabilistically; the reviewer-only experimental annotation is stronger evidence for the exact EC assignment.
- The reviewer-only organism and protein-name annotations were not inputs to the answerability judgment.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a eukaryotic protein-kinase-like catalytic domain, including a glycine-rich region and kinase catalytic motifs, so a protein kinase EC is a much better fit than the glycosidase or monooxygenase choices. Its signal-peptide-like N-terminus and long extension before the kinase domain are more consistent with a specialized secretory kinase than a conventional MAP kinase; the sequence also lacks the characteristic MAPK activation-loop TXY motif. These transferable features favor the broad serine/threonine-protein kinase class, B, over the MAPK-specific alternative A.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Family-level sequence and architecture features credibly distinguish the offered serine/threonine kinase option from the alternatives. They do not independently establish the exact physiological substrates or experimental activity, but that finer proof is not needed to make a meaningful choice among these options."
  },
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry, which assigns EC 2.7.11.1 and records serine- and threonine-phosphorylation reactions. The threonyl reaction carries experimental evidence (ECO:0000269); the underlying paper was not independently reviewed here."
  },
  "important_caveats": [
    "The family-level inference supports the choice probabilistically; the reviewer-only experimental annotation is stronger evidence for the exact EC assignment.",
    "The reviewer-only organism and protein-name annotations were not inputs to the answerability judgment."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The kinase-like sequence supports a protein kinase classification, while the alternatives describe a more specific MAPK class or unrelated enzyme activities; no second option is comparably defensible from the supplied sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry, which assigns EC 2.7.11.1 and records serine- and threonine-phosphorylation reactions. The threonyl reaction carries experimental evidence (ECO:0000269); the underlying paper was not independently reviewed here.",
    "evidence_ids": ["C5", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence has a eukaryotic protein-kinase-like catalytic domain, including a glycine-rich region and kinase catalytic motifs, so a protein kinase EC is a much better fit than the glycosidase or monooxygenase choices. Its signal-peptide-like N-terminus and long extension before the kinase domain are more consistent with a specialized secretory kinase than a conventional MAP kinase; the sequence also lacks the characteristic MAPK activation-loop TXY motif. These transferable features favor the broad serine/threonine-protein kinase class, B, over the MAPK-specific alternative A.",
    "missing_item_specific_fact": "",
    "reason": "Family-level sequence and architecture features credibly distinguish the offered serine/threonine kinase option from the alternatives. They do not independently establish the exact physiological substrates or experimental activity, but that finer proof is not needed to make a meaningful choice among these options."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The kinase-like sequence supports a protein kinase classification, while the alternatives describe a more specific MAPK class or unrelated enzyme activities; no second option is comparably defensible from the supplied sequence."
  },
  "important_caveats": [
    "The family-level inference supports the choice probabilistically; the reviewer-only experimental annotation is stronger evidence for the exact EC assignment.",
    "The reviewer-only organism and protein-name annotations were not inputs to the answerability judgment."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation for Q2PAY3 (ROP17_TOXGO) assigns EC 2.7.11.1 with experimental evidence (ECO:0000269, PubMed:24832449 - Etheridge et al. 2014). The catalytic activity comments confirm both threonine and serine phosphorylation of protein substrates consistent with EC 2.7.11.1 (non-specific serine/threonine protein kinase). The sequence in the benchmark matches the UniProt entry (SHA256 confirmed).

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H2](#evidence-h2), [H5](#evidence-h5), [H6](#evidence-h6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains recognizable protein kinase catalytic motifs (e.g., 'GDLFVGHL' resembling the VAIK/catalytic loop region, a modified 'DFP' in 'CGDFPFGITLD' resembling the DFG motif, and an 'HR'-containing catalytic loop), which immediately eliminates C (3.2.1.55, alpha-L-fucosidase, a glycosidase with GH29/GH95 folds) and D (1.14.13.238, a cytochrome P450 oxidoreductase requiring heme-binding Cys motifs). The remaining challenge is distinguishing A (2.7.11.24, MAP4K) from B (2.7.11.1, generic Ser/Thr protein kinase). MAP4K is a member of the Ste20-like kinase family, an intracellular component of the MAPK signaling cascade with characteristic SH3/PH domain architecture and specific activation-loop sequences. The given sequence begins with a hydrophobic signal peptide (MELVLCFVIITISGVIRESS...), indicating a secreted protein, which is incompatible with the intracellular signaling role of MAP4K. Additionally, the overall domain architecture (a single kinase-like domain embedded in a larger protein with N-terminal secretion signal and rhoptry-like features) does not match the Ste20/MAP4K family. EC 2.7.11.1 serves as the default classification for Ser/Thr protein kinases lacking a more specific EC assignment, making it the appropriate choice for a secreted effector kinase with general Ser/Thr activity.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can identify kinase motifs to eliminate C and D, then use the presence of a signal peptide (secreted protein) and absence of Ste20/MAP4K family features to distinguish B from A. This relies on transferable knowledge of MAP4K biology (intracellular, Ste20-like, MAPK cascade member) and the convention that EC 2.7.11.1 is the default for Ser/Thr kinases without more specific classification.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options C and D are eliminated by basic enzyme class identification from sequence features. Between A and B, the signal peptide and non-Ste20 architecture provide a clear basis for selecting B over A. No ambiguity remains among the offered choices.


### Important caveats

- The distinction between EC 2.7.11.1 (generic Ser/Thr kinase) and EC 2.7.11.24 (MAP4K) relies on recognizing that EC 2.7.11.1 is the default category; a model unfamiliar with EC nomenclature conventions might struggle with this distinction.
- The kinase domain in ROP17 is somewhat atypical (it is described in literature as having an unusual kinase fold), but the presence of canonical motifs is sufficient for family-level classification.
- The reviewer-only evidence confirms the annotation but was not available to the evaluated model; the reasoning argument stands independently on sequence features and general kinase biology.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable protein kinase catalytic motifs (e.g., 'GDLFVGHL' resembling the VAIK/catalytic loop region, a modified 'DFP' in 'CGDFPFGITLD' resembling the DFG motif, and an 'HR'-containing catalytic loop), which immediately eliminates C (3.2.1.55, alpha-L-fucosidase, a glycosidase with GH29/GH95 folds) and D (1.14.13.238, a cytochrome P450 oxidoreductase requiring heme-binding Cys motifs). The remaining challenge is distinguishing A (2.7.11.24, MAP4K) from B (2.7.11.1, generic Ser/Thr protein kinase). MAP4K is a member of the Ste20-like kinase family, an intracellular component of the MAPK signaling cascade with characteristic SH3/PH domain architecture and specific activation-loop sequences. The given sequence begins with a hydrophobic signal peptide (MELVLCFVIITISGVIRESS...), indicating a secreted protein, which is incompatible with the intracellular signaling role of MAP4K. Additionally, the overall domain architecture (a single kinase-like domain embedded in a larger protein with N-terminal secretion signal and rhoptry-like features) does not match the Ste20/MAP4K family. EC 2.7.11.1 serves as the default classification for Ser/Thr protein kinases lacking a more specific EC assignment, making it the appropriate choice for a secreted effector kinase with general Ser/Thr activity.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can identify kinase motifs to eliminate C and D, then use the presence of a signal peptide (secreted protein) and absence of Ste20/MAP4K family features to distinguish B from A. This relies on transferable knowledge of MAP4K biology (intracellular, Ste20-like, MAPK cascade member) and the convention that EC 2.7.11.1 is the default for Ser/Thr kinases without more specific classification."
  },
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H2",
      "H5",
      "H6"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation for Q2PAY3 (ROP17_TOXGO) assigns EC 2.7.11.1 with experimental evidence (ECO:0000269, PubMed:24832449 - Etheridge et al. 2014). The catalytic activity comments confirm both threonine and serine phosphorylation of protein substrates consistent with EC 2.7.11.1 (non-specific serine/threonine protein kinase). The sequence in the benchmark matches the UniProt entry (SHA256 confirmed)."
  },
  "important_caveats": [
    "The distinction between EC 2.7.11.1 (generic Ser/Thr kinase) and EC 2.7.11.24 (MAP4K) relies on recognizing that EC 2.7.11.1 is the default category; a model unfamiliar with EC nomenclature conventions might struggle with this distinction.",
    "The kinase domain in ROP17 is somewhat atypical (it is described in literature as having an unusual kinase fold), but the presence of canonical motifs is sufficient for family-level classification.",
    "The reviewer-only evidence confirms the annotation but was not available to the evaluated model; the reasoning argument stands independently on sequence features and general kinase biology."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are eliminated by basic enzyme class identification from sequence features. Between A and B, the signal peptide and non-Ste20 architecture provide a clear basis for selecting B over A. No ambiguity remains among the offered choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "EC_number_0111",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation for Q2PAY3 (ROP17_TOXGO) assigns EC 2.7.11.1 with experimental evidence (ECO:0000269, PubMed:24832449 - Etheridge et al. 2014). The catalytic activity comments confirm both threonine and serine phosphorylation of protein substrates consistent with EC 2.7.11.1 (non-specific serine/threonine protein kinase). The sequence in the benchmark matches the UniProt entry (SHA256 confirmed).",
    "evidence_ids": ["C4", "C5", "C6", "H2", "H5", "H6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains recognizable protein kinase catalytic motifs (e.g., 'GDLFVGHL' resembling the VAIK/catalytic loop region, a modified 'DFP' in 'CGDFPFGITLD' resembling the DFG motif, and an 'HR'-containing catalytic loop), which immediately eliminates C (3.2.1.55, alpha-L-fucosidase, a glycosidase with GH29/GH95 folds) and D (1.14.13.238, a cytochrome P450 oxidoreductase requiring heme-binding Cys motifs). The remaining challenge is distinguishing A (2.7.11.24, MAP4K) from B (2.7.11.1, generic Ser/Thr protein kinase). MAP4K is a member of the Ste20-like kinase family, an intracellular component of the MAPK signaling cascade with characteristic SH3/PH domain architecture and specific activation-loop sequences. The given sequence begins with a hydrophobic signal peptide (MELVLCFVIITISGVIRESS...), indicating a secreted protein, which is incompatible with the intracellular signaling role of MAP4K. Additionally, the overall domain architecture (a single kinase-like domain embedded in a larger protein with N-terminal secretion signal and rhoptry-like features) does not match the Ste20/MAP4K family. EC 2.7.11.1 serves as the default classification for Ser/Thr protein kinases lacking a more specific EC assignment, making it the appropriate choice for a secreted effector kinase with general Ser/Thr activity.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can identify kinase motifs to eliminate C and D, then use the presence of a signal peptide (secreted protein) and absence of Ste20/MAP4K family features to distinguish B from A. This relies on transferable knowledge of MAP4K biology (intracellular, Ste20-like, MAPK cascade member) and the convention that EC 2.7.11.1 is the default for Ser/Thr kinases without more specific classification."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are eliminated by basic enzyme class identification from sequence features. Between A and B, the signal peptide and non-Ste20 architecture provide a clear basis for selecting B over A. No ambiguity remains among the offered choices."
  },
  "important_caveats": [
    "The distinction between EC 2.7.11.1 (generic Ser/Thr kinase) and EC 2.7.11.24 (MAP4K) relies on recognizing that EC 2.7.11.1 is the default category; a model unfamiliar with EC nomenclature conventions might struggle with this distinction.",
    "The kinase domain in ROP17 is somewhat atypical (it is described in literature as having an unusual kinase fold), but the presence of canonical motifs is sufficient for family-level classification.",
    "The reviewer-only evidence confirms the annotation but was not available to the evaluated model; the reasoning argument stands independently on sequence features and general kinase biology."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "Q2PAY3",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "5efc2102f3d29e95c5037c2e1a6472b612c3daed4aec52f46cef941c11510320",
  "benchmark_sequence_length": 608,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 87,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2006-02-07",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "current_source_sequence_sha256": "5efc2102f3d29e95c5037c2e1a6472b612c3daed4aec52f46cef941c11510320",
  "current_source_sequence_length": 608,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 86,
  "selected_historical_version": {
    "accession": "Q2PAY3",
    "database": "Swiss-Prot",
    "entryVersion": 86,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "ROP17_TOXGO",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "selected_historical_source_sequence_sha256": "5efc2102f3d29e95c5037c2e1a6472b612c3daed4aec52f46cef941c11510320",
  "selected_historical_source_sequence_length": 608,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 86,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"Q2PAY3\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":87,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2006-02-07\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"CAJ27112.1\",\"source\":\"EMBL\"}],\"lineage\":[\"Eukaryota\",\"Sar\",\"Alveolata\",\"Apicomplexa\",\"Conoidasida\",\"Coccidia\",\"Eucoccidiorida\",\"Eimeriorina\",\"Sarcocystidae\",\"Toxoplasma\"],\"scientificName\":\"Toxoplasma gondii\",\"taxonId\":5811}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"CAJ27112.1\",\"source\":\"EMBL\"}],\"value\":\"Rhoptry protein 17\"}},{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"34180401\",\"source\":\"PubMed\"}],\"value\":\"TgROP17\"}}],\"flag\":\"Precursor\",\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"24832449\",\"source\":\"PubMed\"}],\"value\":\"2.7.11.1\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Serine/threonine-protein kinase ROP17\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"CATALYTIC ACTIVITY\",\"reaction\":{\"ecNumber\":\"2.7.11.1\",\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"24832449\",\"source\":\"PubMed\"}],\"name\":\"L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+)\",\"reactionCrossReferences\":[{\"database\":\"Rhea\",\"id\":\"RHEA:46608\"},{\"database\":\"Rhea\",\"id\":\"RHEA-COMP:11060\"},{\"database\":\"Rhea\",\"id\":\"RHEA-COMP:11605\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:15378\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:30013\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:30616\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:61977\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:456216\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"CATALYTIC ACTIVITY\",\"reaction\":{\"ecNumber\":\"2.7.11.1\",\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"24832449\",\"source\":\"PubMed\"}],\"name\":\"L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+)\",\"reactionCrossReferences\":[{\"database\":\"Rhea\",\"id\":\"RHEA:17989\"},{\"database\":\"Rhea\",\"id\":\"RHEA-COMP:9863\"},{\"database\":\"Rhea\",\"id\":\"RHEA-COMP:11604\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:15378\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:29999\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:30616\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:83421\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:456216\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Etheridge R.D.\",\"Alaganan A.\",\"Tang K.\",\"Lou H.J.\",\"Turk B.E.\",\"Sibley L.D.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"24832449\"},{\"database\":\"DOI\",\"id\":\"10.1016/j.chom.2014.04.002\"}],\"citationType\":\"journal article\",\"firstPage\":\"537\",\"id\":\"24832449\",\"journal\":\"Cell Host Microbe\",\"lastPage\":\"550\",\"publicationDate\":\"2014\",\"title\":\"The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice.\",\"volume\":\"15\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":2,\"referencePositions\":[\"IDENTIFICATION BY MASS SPECTROMETRY\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"INTERACTION WITH ROP5\",\"SUBCELLULAR LOCATION\",\"DISRUPTION PHENOTYPE\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2PAY3.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q2PAY3.json",
  "source_sha256": "6706ba31663e0eeb6d66fbdf81baeb771e31266ea82e6b187e4763189ddeb230",
  "retrieved_utc": "2026-11-02T04:30:36.273311+00:00",
  "json_pointer": "/references/6",
  "excerpt": "{\"citation\":{\"authors\":[\"Guo M.\",\"Sun J.\",\"Wang W.T.\",\"Liu H.Y.\",\"Liu Y.H.\",\"Qin K.R.\",\"Hu J.R.\",\"Li X.Y.\",\"Liu H.L.\",\"Wang W.\",\"Chen Z.Y.\",\"Wang C.F.\",\"Wang H.L.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"34180401\"},{\"database\":\"DOI\",\"id\":\"10.14411/fp.2021.016\"}],\"citationType\":\"journal article\",\"firstPage\":\"0\",\"id\":\"34180401\",\"journal\":\"Folia Parasitol.\",\"lastPage\":\"0\",\"publicationDate\":\"2021\",\"title\":\"Toxoplasma gondii ROP17 promotes autophagy via the Bcl-2-Beclin 1 pathway.\",\"volume\":\"68\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":7,\"referencePositions\":[\"FUNCTION\",\"INTERACTION WITH HUMAN BCL2\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86",
  "source_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "retrieved_utc": "2026-11-02T04:30:38.452820+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   ROP17_TOXGO             Reviewed;         608 AA.\nAC   Q2PAY3;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   07-FEB-2006, sequence version 1.\nDT   28-JAN-2026, entry version 86.\nDE   RecName: Full=Serine/threonine-protein kinase ROP17 {ECO:0000305};\nDE            EC=2.7.11.1 {ECO:0000269|PubMed:24832449};\nDE   AltName: Full=Rhoptry protein 17 {ECO:0000312|EMBL:CAJ27112.1};\nDE   AltName: Full=TgROP17 {ECO:0000303|PubMed:34180401};\nDE   Flags: Precursor;\nGN   Name=rop17 {ECO:0000312|EMBL:CAJ27112.1};\nOS   Toxoplasma gondii.\nOC   Eukaryota; Sar; Alveolata; Apicomplexa; Conoidasida; Coccidia;\nOC   Eucoccidiorida; Eimeriorina; Sarcocystidae; Toxoplasma.\nOX   NCBI_TaxID=5811 {ECO:0000312|EMBL:CAJ27112.1};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 86,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86",
  "source_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "retrieved_utc": "2026-11-02T04:30:38.452820+00:00",
  "source_locator": "lines 6-10",
  "excerpt": "DE   RecName: Full=Serine/threonine-protein kinase ROP17 {ECO:0000305};\nDE            EC=2.7.11.1 {ECO:0000269|PubMed:24832449};\nDE   AltName: Full=Rhoptry protein 17 {ECO:0000312|EMBL:CAJ27112.1};\nDE   AltName: Full=TgROP17 {ECO:0000303|PubMed:34180401};\nDE   Flags: Precursor;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 86,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86",
  "source_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "retrieved_utc": "2026-11-02T04:30:38.452820+00:00",
  "source_locator": "lines 24-31",
  "excerpt": "RN   [2] {ECO:0000305}\nRP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, CATALYTIC ACTIVITY,\nRP   INTERACTION WITH ROP5, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.\nRX   PubMed=24832449; DOI=10.1016/j.chom.2014.04.002;\nRA   Etheridge R.D., Alaganan A., Tang K., Lou H.J., Turk B.E., Sibley L.D.;\nRT   \"The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17\nRT   kinases that synergize to control acute virulence in mice.\";\nRL   Cell Host Microbe 15:537-550(2014).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 86,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86",
  "source_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "retrieved_utc": "2026-11-02T04:30:38.452820+00:00",
  "source_locator": "lines 62-69",
  "excerpt": "RN   [7] {ECO:0000305}\nRP   FUNCTION, AND INTERACTION WITH HUMAN BCL2.\nRX   PubMed=34180401; DOI=10.14411/fp.2021.016;\nRA   Guo M., Sun J., Wang W.T., Liu H.Y., Liu Y.H., Qin K.R., Hu J.R., Li X.Y.,\nRA   Liu H.L., Wang W., Chen Z.Y., Wang C.F., Wang H.L.;\nRT   \"Toxoplasma gondii ROP17 promotes autophagy via the Bcl-2-Beclin 1\nRT   pathway.\";\nRL   Folia Parasitol. 68:0-0(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 86,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86",
  "source_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "retrieved_utc": "2026-11-02T04:30:38.452820+00:00",
  "source_locator": "lines 85-90",
  "excerpt": "CC   -!- CATALYTIC ACTIVITY:\nCC       Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] +\nCC         ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-\nCC         COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616,\nCC         ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;\nCC         Evidence={ECO:0000269|PubMed:24832449};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 86,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86)

```json
{
  "evidence_id": "H6",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q2PAY3?format=txt&versions=86",
  "source_sha256": "b556cca06da62f63e90c588009b9095a040ad3bb5a30da56151ae475acf8019a",
  "retrieved_utc": "2026-11-02T04:30:38.452820+00:00",
  "source_locator": "lines 91-96",
  "excerpt": "CC   -!- CATALYTIC ACTIVITY:\nCC       Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP +\nCC         H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-\nCC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,\nCC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;\nCC         Evidence={ECO:0000305|PubMed:24832449};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 86,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/EC_number.json), zero-based source row 111. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
